Home › Funds › GTCR LLC › MRVI
GTCR LLC position in MRVI
MARAVAI LIFESCIENCES HLDGS I · Health Care
GTCR LLC reported holding 20,150,005 shares of MRVI (MARAVAI LIFESCIENCES HLDGS I) in its Q3 2026 13F filing — a position valued at US$154.3M, representing 3.59% of its reported portfolio and ranking #3 among its reported holdings. GTCR LLC has disclosed MRVI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How GTCR LLC's MRVI position evolved
GTCR LLC first disclosed a stake in MRVI in Q3 2023 at 21,681,033 shares (US$216.8M). Across 13 filings, GTCR LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 20,150,005 shares valued at US$154.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 21.68M | $216.81M | New |
| Q4 2023 | 21.68M | $142.01M | Hold |
| Q1 2024 | 21.68M | $187.97M | Hold |
| Q2 2024 | 20.15M | $144.27M | Reduce |
| Q3 2024 | 20.15M | $167.45M | Hold |
| Q4 2024 | 20.15M | $109.82M | Hold |
| Q1 2025 | 20.15M | $44.53M | Hold |
| Q2 2025 | 20.15M | $48.56M | Hold |
| Q3 2025 | 20.15M | $57.83M | Hold |
| Q4 2025 | 20.15M | $65.49M | Hold |
| Q1 2026 | 20.15M | $57.02M | Hold |
| Q2 2026 | 20.15M | $125.74M | Hold |
| Q3 2026 | 20.15M | $154.35M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRVI and 13F data
MRVI (MARAVAI LIFESCIENCES HLDGS I) is a Health Care company. 35 other funds we track also report a position in MRVI — the largest reported positions include BRAIDWELL LP (US$54.3M), 12 West Capital Management LP (US$44.1M), Ophir Asset Management Pty Ltd (US$30.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRVI
- BRAIDWELL LP 8.70M sh · $54.31M · Q2 2026
- 12 West Capital Management LP 7.06M sh · $44.06M · Q2 2026
- Ophir Asset Management Pty Ltd 4.83M sh · $30.12M · Q2 2026
- GENERAL AMERICAN INVESTORS CO INC 1.72M sh · $13.15M · Q3 2026
- Philosophy Capital Management LLC 1.90M sh · $11.86M · Q2 2026
FAQ
How long has GTCR LLC held MRVI?
GTCR LLC has disclosed MRVI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is GTCR LLC's current position in MRVI?
As of Q3 2026, GTCR LLC holds 20.15M shares of MRVI (MARAVAI LIFESCIENCES HLDGS I), valued at $154.35M, representing 3.59% of its reported portfolio and ranking #3.
Has GTCR LLC been buying or selling MRVI?
In the latest 13F filing (Q3 2026), GTCR LLC held unchanged its position in MRVI.
Which other funds hold MRVI?
Other major institutional holders of MRVI include BRAIDWELL LP, 12 West Capital Management LP, Ophir Asset Management Pty Ltd, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.